ANSTO Publications Online >
Journal Publications >
Journal Articles >

Please use this identifier to cite or link to this item: http://apo.ansto.gov.au/dspace/handle/10238/3043

Title: Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.
Authors: Kas, A
Bottlaender, M
Gallezot, JD
Vidailhet, M
Villafane, G
Gregoire, MC
Coulon, C
Valette, H
Dolle, F
Ribeiro, MJ
Hantraye, P
Remy, P
Keywords: Tobacco Smokes
Positron Computed Tomography
Diseases
Patients
Nicotine
Receptors
Issue Date: Sep-2009
Publisher: Nature Publishing Group
Citation: Kas, A., Bottlaender, M., Gallezot, J. D., Vidailhet, M., Villafane, G., Gregoire, M. C., et al. (2009). Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism, 29(9), 1601-1608.
Abstract: Smoking is associated with a lower incidence of Parkinson's disease (PD), which might be related to a neuroprotective action of nicotine. Postmortem studies have shown a decrease of cerebral nicotinic acetylcholine receptors (nAChRs) in PD. In this study, we evaluated the decrease of nAChRs in PD in vivo using positron emission tomography (PET), and we explored the relationship between nAChRs density and PD severity using both clinical scores and the measurement of striatal dopaminergic function. Thirteen nondemented patients with PD underwent two PET scans, one with 6-[18F]fluoro-3,4-dihydroxy-L-phenylalanine (6-[18F]fluoro-L-DOPA) to measure the dopaminergic function and another with 2-[18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine (2-[18F]fluoro-A-85380), a radiotracer with high affinity for the nAChRs. Distribution volumes (DVs) of 2-[18F]fluoro-A-85380 measured in the PD group were compared with those obtained from six nonsmoking healthy controls, with regions-of-interest and voxel-based approaches. Both analyses showed a significant (P <0.05) decrease of 2-[18F]fluoro-A-85380 DV in the striatum (−10%) and substantia nigra (−14.9%) in PD patients. Despite the wide range of PD stages, no correlation was found between DV and the clinical and PET markers of PD severity. © 2009, Nature Publishing Group.
URI: http://dx.doi.org/10.1038/jcbfm.2009.74
http://apo.ansto.gov.au/dspace/handle/10238/3043
ISSN: 0271-678X
Appears in Collections:Journal Articles

Files in This Item:

There are no files associated with this item.

Items in APO are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback